NCT01232257View on ClinicalTrials.gov

Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Chronic Kidney DiseaseChronic Kidney FailureEnd Stage Kidney DiseaseEnd Stage Renal Disease
Interventions
DRUG

N-acetylcysteine

4 gifts of N-acetylcysteine 600 mg BID

Trial Locations (1)

3584 CX

UMC Utrecht, Utrecht

All Listed Sponsors
lead

A.C. Abrahams

OTHER

NCT01232257 - Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD) | Biotech Hunter | Biotech Hunter